Gemini Therapeutics, Inc.

NasdaqGM:GMTX Stock Report

Mkt Cap: US$58.5m

This company is no longer active

The company may no longer be operating, as it may be out of business. Find out why through their latest events.

Gemini Therapeutics Company Information

Gemini Therapeutics, Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Gemini Therapeutics, Inc.
  • Ticker: GMTX
  • Exchange: NasdaqGM
  • Founded: 2015
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: US$58.493m
  • Shares outstanding: 43.33m
  • Website:

Number of Employees


  • Gemini Therapeutics, Inc.
  • 300 One Kendall Square
  • 3rd Floor
  • Cambridge
  • Massachusetts
  • 2139
  • United States


TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
GMTXNasdaqGM (Nasdaq Global Market)YesCommon StockUSUSDAug 2020

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/12/30 00:00
End of Day Share Price2022/12/29 00:00
Annual Earnings2021/12/31

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.